• Aspergillus fumigatus, IgE
  • Interleukin 2 (IL2) Receptor
  • Anti-SARS-CoV-2 (Coronavirus), IgG
  • Toxoplasma gondii Antibody, IgM
  • Corticotropin Releasing Hormone (CRH)
  • Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
  • Fentanyl, Serum
  • Cardiac Myosin Binding Protein C (MYBPC3) Mutation Analysis
  • Triiodothyronine (T3), Reverse
  • Aldolase, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Interpretation
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.
Loading...